Q-omics provides the consensus-scored RPSAP72 profile across patient tissues and cancer cell-line models. RPSAP72 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, RPSAP72 is differentially expressed in 4, with the highest sampling consensus in HNSC. Additionally, RPSAP72 RNA expression shows 15,003 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight UCEC, HNSC, and THYM as cancer lineages where RPSAP72 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RPSAP72 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RPSAP72 survival associations across molecular data types. RPSAP72 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RPSAP72 RNA expression–survival associations across cancer types. High RPSAP72 expression shows unfavorable associations in UCEC and MESO, but favorable associations in ACC, BLCA, BRCA and UCS. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCEC as the clearest survival context for RPSAP72 RNA expression.
This table summarizes RPSAP72 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for RPSAP72. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RPSAP72 shows lower tumor expression in HNSC, BRCA, THCA and COAD. The HNSC box plot shows higher RPSAP72 RNA expression in normal versus tumor tissue (log2 FC = −0.144, t-test p < 0.001).
This table shows molecular features associated with RPSAP72 in patient tissues and cancer cell lines. In patient samples, RPSAP72 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
